Join HOC for an engaging evening as we explore the remarkable journey of hemophilia treatment—from its earliest approaches to today’s cutting-edge gene therapy.

We’re honored to welcome Molly McCue, Key Account Manager at BioMarin, and HOC Community Member, Dave Novak. They’ll share powerful insights and personal experiences on the advancements in care.

📅 Date: Tuesday, July 15, 2025
📍 Location: Hinterland Brewery
⏱ Time: 6:00 PM
🎟 RSVP to Heather at heatherh@hocgb.org or 920-965-0606 to secure your spot!

Your presence would be greatly valued, and we look forward to an engaging and informative evening.

*This is an informational session. Roctavian is FDA-approved for adults 18 and older with severe hemophilia A.